Validations. Estimated Start Date: [********]. ------------------------------------------------------------ --------------------------------------------------------- Validations Stage Expected Cost ------------------------------------------------------------ --------------------------------------------------------- [********] SP does not plan to perform process validation on the clinical lots ------------------------------------------------------------ --------------------------------------------------------- [********] [********] [********] Perform additional work on a time and materials basis at [********]. ------------------------------------------------------------ --------------------------------------------------------- [********] TBD - Price to be mutually agreed upon at a later date ------------------------------------------------------------ --------------------------------------------------------- [********] [********] ------------------------------------------------------------ --------------------------------------------------------- [********] [********] ------------------------------------------------------------ --------------------------------------------------------- [********] TBD - Price to be mutually agreed upon at a later date. [********] ------------------------------------------------------------ --------------------------------------------------------- Estimated Total $[********] without terminal sterilization validation ------------------------------------------------------------ ---------------------------------------------------------
Appears in 2 contracts
Sources: Clinical Supply Agreement (Drugabuse Sciences Inc), Clinical Supply Agreement (Drugabuse Sciences Inc)